Acelrx Pharmaceuticals reported $442K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.44M
Acura Pharmaceuticals ACUR:US 613K 31K
Baxter International BAX:US $ 3707M 193M
Becton, Dickinson and BDX:US $ 5011M 16M
Cara Therapeutics CARA:US $ 4.79M 3.97M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Smiths SMIN:LN 1.19B 64M
Teva Pharmaceutical TEVA:IT 3.66B 439M
Xeris Pharmaceuticals Inc XERS:US $ 22.07M 644K